Methamphetamine Addiction

Methamphetamine addiction can affect sleep, health, relationships, and daily life. Learn how to recognize problems, find treatment, and support someone you care about.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

Finding Help for Methamphetamine Use

If methamphetamine is taking over sleep, health, or daily life, you do not have to work out the next step alone. Treatment can help people change harmful methamphetamine use. Methamphetamine is a powerful stimulant, a drug that speeds up activity in the brain and body. A healthcare professional can assess your symptoms and help you choose care.[1]

Treatment may include contingency management, which provides rewards for agreed goals such as attending appointments, and counseling to practice ways of handling cravings and avoiding renewed use. Medical care can address problems such as severe sleep loss, heart symptoms, or depression alongside treatment for methamphetamine use.[1][2]

When Methamphetamine Exposure Needs Emergency Help

Chest pain, high fever, or a seizure need emergency medical care. So does psychosis when safety is at risk. Psychosis can include hearing voices or believing someone is trying to hurt you when that is not happening. In the United States, call 911 for a life-threatening emergency.[2]

If breathing is slow or stopped, give naloxone if available because an opioid, such as fentanyl or heroin, may also be involved. Naloxone reverses opioid effects but does not reverse the harmful effects of methamphetamine.[2][3][1][4]

Fast Facts About Methamphetamine

These points summarize the drug’s forms, overdose burden, and treatment options.

  • Methamphetamine may appear as powder, crystals, pills, or, less commonly, liquid, and nonmedical use can occur by swallowing, smoking, snorting, injecting, or rectal administration.[5]
  • In 2023, 34,855 U.S. overdose deaths involved psychostimulants with abuse potential, a category composed mostly of methamphetamine but not limited to it.[4]
  • There is no medication approved by the U.S. Food and Drug Administration specifically for methamphetamine use disorder, while contingency management (a treatment offering tangible rewards for recovery-related behaviors) has the strongest evidence among behavioral treatments for stimulant use disorder.[4][2][1]

Medical and Nonmedical Methamphetamine Use

Desoxyn is a prescription methamphetamine product. Its U.S. Food and Drug Administration (FDA) labeling lists treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 years and older.[6][1] The label also warns about misuse, addiction, overdose, and death, so prescribed use requires assessment and monitoring.[6] Methamphetamine is a controlled drug classified as Schedule II, with strict prescribing rules. It is legally available only through a prescription that cannot be refilled.[1]

Medical use differs from nonmedical use in the product, dose control, purpose, and oversight. A regulated prescription has a known formulation and is monitored by a clinician. Nonmedical use includes using illicit methamphetamine or using any prescription outside its directions. Most methamphetamine used in the United States is illicitly manufactured rather than dispensed as medicine.[1]

If prescribed use becomes hard to control or causes concerning symptoms, a clinician can assess whether stimulant use disorder or another health concern is present.[1][2]

How Methamphetamine Affects Brain Signaling

Methamphetamine increases the release of chemical messengers, including dopamine. Dopamine signaling is involved in reward and reinforcement, the processes through which an experience can encourage someone to repeat a behavior. Methamphetamine also affects other signaling systems, so dopamine alone does not explain every physical or mental effect.[5]

Methamphetamine Forms and Routes of Use

Illicit methamphetamine may be sold as powder, shiny crystals, pills made to resemble prescriptions, or rarely as liquid. “Crystal meth,” “ice,” and “Tina” commonly refer to crystals. “Meth,” “speed,” and “crank” may refer to powder.[5]

A route of use is the way a substance enters the body. Oral use means swallowing. Nasal insufflation means snorting. Vapor inhalation means smoking. Intravenous use means injecting into a vein. Rectal administration means placing a substance in the rectum. These terms may come up when a clinician asks how you used the drug.[5]

The route affects how quickly effects begin and can change the risks involved. Smoking and injecting can produce rapid, intense effects. The risks differ between smoking and snorting methamphetamine.[5][1]

Snorting and swallowing have different timing, but a slower onset does not establish safety. One clinical review reports a plasma half-life of about 9 to 11 hours, meaning the blood level takes roughly that long to fall by half.[5][1]

Injection also introduces risks unrelated to the stimulant’s direct effects. Sharing syringes or other injection equipment can transmit human immunodeficiency virus (HIV), hepatitis B, and hepatitis C and can contribute to serious bacterial infections such as infective endocarditis, an infection of the heart’s inner lining or valves.[2][1]

How Do Methamphetamine Use, Dependence, and Use Disorder Differ?

These terms describe different situations. Keeping them separate reduces stigma and helps people seek the right level of care.

Term What It Means What It Does Not Establish
Use Taking methamphetamine, whether prescribed or nonmedical A diagnosis by itself
Misuse Using a prescription outside its directions or using a drug nonmedically That the person necessarily has a use disorder
Intoxication Temporary physical, behavioral, or mental effects occurring during or soon after use A long-term pattern or diagnosis
Physical dependence Adaptation in which stopping or reducing repeated use can produce withdrawal Loss of control by itself
Methamphetamine use disorder A diagnosed pattern causing serious distress or problems with health, relationships, work, school, or other responsibilities A moral failing or lack of willpower

Physical dependence and use disorder can overlap, but neither automatically proves the other. A person can experience withdrawal after repeated methamphetamine use without meeting all criteria for a stimulant use disorder.[1]

How Methamphetamine Use Disorder Is Diagnosed

Clinicians diagnose stimulant use disorder using criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).[5][1] The pattern must include at least two symptoms within 12 months and cause serious distress or interfere with daily life.[5][1]

Possible criteria include:

  • Taking more or using longer than intended
  • Repeated unsuccessful efforts to reduce or control use
  • Spending substantial time obtaining, using, or recovering
  • Craving
  • Not meeting major responsibilities at home, work, or school
  • Continuing despite significant relationship or social problems
  • Reducing important activities because of use
  • Repeated use in hazardous situations
  • Continuing despite a known physical or psychological problem
  • Tolerance, meaning needing more to obtain a similar effect
  • Withdrawal after stopping or reducing use

Under DSM-5, two or three criteria indicate mild disorder.[5][1] Four or five criteria indicate moderate disorder. Six or more criteria indicate severe disorder. “Addiction” is commonly used to describe severe substance use disorder, although a clinician may use the formal diagnostic term.[5][1]

A list cannot diagnose someone. Context matters, including prescribed use, other physical or mental health conditions, other substances, and whether symptoms occur together within the same 12-month period.

When to Seek an Assessment for Methamphetamine Use

An assessment may be useful when methamphetamine use is accompanied by repeated inability to cut down, intense craving, escalating use, missed responsibilities, hazardous situations, withdrawal, or continued use despite health or relationship consequences.

Concern is also warranted after an overdose, psychosis (difficulty distinguishing what is real), severe sleep loss, heart or blood-vessel symptoms, injection-related infection, or an emergency or urgent-care visit for the effects of stimulant use, withdrawal, or an overdose. Assessment can address immediate safety and longer-term goals even if the person is not ready to stop.[1][2][4][7]

Drug testing alone cannot diagnose an addiction. A urine screening test can sometimes suggest drug use when another medicine caused the result. Tests can also miss substances, depending on what the test checks for and when it is taken. A clinician considers test results alongside your symptoms, medication list, examination, and account of what happened.[2]

What to bring up at your first appointment

  • When you last used methamphetamine and what happened afterward.
  • Other drugs, alcohol, prescriptions, or supplements you use.
  • Changes in sleep, mood, thinking, teeth, or physical health.
  • What help you want and what might make appointments hard to attend.

You can write these down or ask someone you trust to help you prepare.

Short-Term Methamphetamine Effects

Methamphetamine can temporarily increase wakefulness, energy, confidence, talkativeness, activity, and sex drive while decreasing appetite. It can also produce euphoria, an intense sense of pleasure or well-being.[1][8]

These desired effects can occur alongside anxiety, paranoia, increased blood pressure, rapid or irregular heartbeat, and agitation. Serious events include stroke, kidney injury, overheating, psychosis, nonfatal overdose, and death.[1][4]

A “crash” may follow as euphoria and stimulation wear off. Some people repeat use in an attempt to extend the effects or avoid the crash. Repeated binge-pattern use can increase health risks and the likelihood of developing a use disorder.[1]

Methamphetamine’s plasma half-life is about 9–11 hours depending on route, so its blood level falls over many hours.[5][1][4] Difficulty sleeping, confusion, anxiety, extreme suspicion of others, and severe restlessness are recognized concerns during methamphetamine use and related complications.[5][1][4]

Methamphetamine Overdose Signs and Emergency Response

A stimulant overdose is sometimes called “overamping.” It may look different from a typical opioid overdose. Instead of only slowed breathing and unresponsiveness, the harmful effects of stimulants can include chest pain, dangerous overheating, seizures, or losing touch with reality.[4][1]

Which Methamphetamine Symptoms Need Emergency Care?

High fever, seizures, chest pain, and severe confusion or psychosis after stimulant use need urgent medical assessment. Psychosis means difficulty distinguishing what is real. Thoughts of suicide also need immediate support, especially during withdrawal.[2][3]

Examples that need urgent attention include:

  • Chest pain or a high fever.[2]
  • A seizure.[2]
  • Psychosis, such as hallucinations or delusions, particularly when safety is at risk.[2][1]
  • Suicidal thoughts or behavior.[2]
  • Slow or stopped breathing, which may indicate an opioid is also involved.[1]

In the United States, call 911 for a life-threatening emergency.[3][2] For suicidal thoughts or urges to harm yourself, call or text 988 for immediate support. Call 911 when there is an immediate threat to life.[3][2] These signs need prompt help rather than waiting for a home drug test to identify the substance.[3][2]

When Methamphetamine and Opioids May Both Be Involved

Methamphetamine and opioids may be used together intentionally or may be present in an unpredictable drug supply. In the national mortality analysis, 73% of stimulant-involved overdose deaths also involved opioids.[4]

Slow or stopped breathing may indicate opioid involvement. Give naloxone or nalmefene, medicines that reverse an opioid overdose, if available, and seek emergency help. These medicines reverse opioid effects but do not reverse the harmful effects of methamphetamine, so the person still needs emergency care for possible overheating, seizure, agitation, stroke, or heart complications.[4][1]

Drug-checking approaches such as fentanyl test strips may help people understand what is in their drug supply. They do not remove the risks of methamphetamine itself. The national mortality report also cites drug-checking findings suggesting that many fatal stimulant-opioid combinations involved intentional use of separate products, rather than unrecognized contamination alone.[4][1]

Some people report combining opioids and stimulants to balance their effects. Despite that perceived benefit, co-use can increase overdose risk, and an overdose involving both may require treatment for both opioid and stimulant effects.[4]

Methamphetamine-Related Psychosis

Methamphetamine-related psychosis means losing reliable contact with reality. Symptoms may include hallucinations, such as hearing or seeing things others do not, and delusions, which are firmly held false beliefs. Severe paranoia can also occur.[1]

Methamphetamine can produce psychotic symptoms during intoxication, withdrawal, or a period of ongoing use. Symptoms may sometimes continue when the person no longer appears intoxicated. A history of methamphetamine-associated psychosis can be followed by another episode, and heavy drinking and stress have been associated with higher odds of recurrence.[1]

Psychosis in a person who uses methamphetamine is not automatically caused solely by the drug. Symptoms caused by substances can resemble those of another mental health condition, such as schizophrenia or bipolar disorder. Early in care, distinguishing substance-induced psychosis from psychosis related to an underlying disorder can be difficult.[9]

Clinicians consider the timing of substance use, when symptoms began, whether they continue during periods without substance use, prior episodes, other medical findings, and information from people who know the person. Correctly identifying the likely cause matters because treatment and follow-up needs may differ.[9]

Seek emergency help when psychosis creates an immediate safety risk or involves severe agitation. Assessment and treatment should address urgent mental health concerns without waiting for drug-test confirmation.[2][4]

Clinicians can treat psychosis while checking for other possible causes. Treatment may include a calm, closely monitored setting and medicine to reduce hallucinations, delusions, or severe agitation. The choice of medicine depends on the person’s symptoms, other health conditions, possible side effects, and response to care. Persistent symptoms need follow-up and may require ongoing treatment.[2]

Methamphetamine Withdrawal and Sleep Disruption

Methamphetamine increases wakefulness, and repeated use can be accompanied by insomnia. Sleep problems can also occur after repeated use stops. This means sleep difficulties need to be understood in relation to both recent use and withdrawal, rather than treated as proof of one particular phase.[1]

After repeated use stops, methamphetamine withdrawal symptoms may begin quickly and commonly peak two to three days after the last use. The early, more intense phase may last about a week, although timing and severity vary.[1]

Symptoms can include:

  • Depression or low mood
  • Anxiety and irritability
  • Sleep disturbance
  • Pain and general discomfort
  • Difficulty concentrating
  • Strong cravings

These symptoms are described in the National Institute on Drug Abuse’s methamphetamine guidance.[1]

Many outpatient withdrawal symptoms are mild to moderate and short-lived, and a 2022 clinical review reports that most are absent after five weeks. This is a general research finding, not a deadline for feeling better. Craving may decline more slowly and contribute to renewed use during the first weeks and months.[5]

Low mood, anxiety, or craving can persist for several months in some people. Severe, worsening, or unexpectedly persistent symptoms need assessment for depression, another mental health condition, physical illness, or effects of another substance rather than being assumed to be withdrawal.[1][2]

Psychosis, severe agitation, or symptoms suggesting an overdose require urgent assessment rather than being assumed to be withdrawal. Withdrawal management addresses immediate symptoms and safety. Follow-up assessment addresses ongoing health concerns and possible stimulant use disorder.[2][4]

A 2022 clinical review found that no medicine consistently treated stimulant withdrawal itself. That does not mean you must endure symptoms without help. A clinician can address specific problems, such as persistent psychosis, and assess whether depression or another health condition also needs treatment.[5][2]

Tell the clinician about other drugs, alcohol, and medicines you use. Opioid use and other physical or mental health conditions can change which treatments are appropriate. Ask for an individual medication plan instead of following a generic withdrawal schedule.[2]

How Methamphetamine Can Affect Long-Term Health

Repeated or prolonged methamphetamine use can be linked with problems affecting the heart, mental health, teeth, nutrition, skin, lungs, memory, and thinking. When researchers say two things are “associated,” they mean those things occur together. That does not prove methamphetamine was the sole cause of every health problem in every person.[10][1]

Methamphetamine and Heart or Blood Vessel Problems

Long-term stimulant use is associated with diseases of the heart and blood vessels, including stroke and heart failure. A stimulant overdose can also cause serious heart or blood-vessel problems.[4][1]

Among deaths involving stimulants without opioids in 46 states and Washington, DC, from January 2021 through June 2024, 38.7% of people had a known history of heart or blood-vessel disease.[4] The corresponding proportion was 21.2% among deaths involving both stimulants and opioids.[4]

These figures describe people who died and do not estimate disease risk among everyone who uses methamphetamine. Records may not have captured every person’s heart or blood-vessel conditions, and methamphetamine was not the only stimulant included in all analyses.[4]

Heart and blood-vessel complications can be part of a stimulant overdose and need urgent assessment. Outside an emergency, discussing stimulant use and your history of heart or blood-vessel problems during a health visit may help identify risks that need further evaluation.[4]

Methamphetamine, Thinking, and Mental Health

Long-term methamphetamine use has been associated with anxiety, confusion, insomnia, mood disturbance, memory problems, difficulty learning or remembering words and information, and slower reaction or movement speed. More research is needed to clarify how much and how consistently thinking and memory change over time.[1]

The evidence does not establish a single explanation for every person’s thinking or mental health symptoms. Clinical assessment includes the history of stimulant use, current symptoms, examination findings, and other health concerns rather than assuming that methamphetamine explains everything.[2][1]

If concentration is making treatment difficult, useful questions include: “Could we review one step at a time?” and “Could I have a written summary?” These are requests to discuss with a provider, not promises about cognitive recovery. Behavioral treatment can require mental effort at a time when stimulant use or withdrawal may make that effort harder.[5]

Infection and Sexual Health Risks With Methamphetamine

Sharing injection equipment can transmit HIV and viral hepatitis and contribute to bacterial infections, including infective endocarditis. Viral hepatitis is a virus-caused liver infection. The National Institute on Drug Abuse also identifies sexual behavior associated with methamphetamine use as a route of increased HIV or hepatitis exposure. It does not imply that everyone who uses methamphetamine has the same exposures.[1]

Do not share injection supplies. A practical question for a healthcare service or a program that helps people reduce drug-related harm is: “Where can I obtain sterile supplies, and what infection assessment is appropriate for my exposures?” Shared-equipment risks support addressing these needs even when stopping use is not an immediate goal.[1][2]

Because injection stimulant use can lead to HIV, viral hepatitis, bacterial infections, and infective endocarditis, concerning symptoms after injection should be assessed by a clinician.[2][1]

Dental Problems and Methamphetamine Use

The phrase “meth mouth” refers to extensive tooth decay and tooth loss reported in some people who use methamphetamine. Other findings can include dry mouth, poor oral hygiene, heavy tooth wear, and widespread cavities.[8][1]

Xerostomia is the medical term for dry mouth. A dental review describes reduced saliva, nutrition, and oral hygiene as concerns in people using methamphetamine. These findings need individual assessment: dental disease should not be treated as proof that someone uses the drug.[8][11]

Regular dental care and daily oral hygiene matter. Ask the dentist how to care for your teeth and manage dry mouth. Extensive damage deserves an assessment and a treatment plan, rather than an assumption that nothing can be done.[8][1]

Tell the dentist about recent methamphetamine exposure because it can affect heart and blood-vessel risks and decisions about dental medicines. An older dental review cautions about local anesthetics (medicines that numb an area) containing vasoconstrictors, ingredients that narrow blood vessels. These may create additional heart or blood-vessel risks in someone taking methamphetamine. The dentist should make an individualized decision.[8]

Methamphetamine, Other Drugs, and Overlapping Health Problems

A major documented risk at the population level is co-use with opioids, particularly fentanyl and heroin. In 2019, 54% of deaths involving psychostimulants also involved an opioid.[5][4] More recent surveillance found opioid co-involvement in 73% of stimulant-involved overdose deaths during January 2021 through June 2024.[5][4] The latter figure covers a broader stimulant category, so these percentages are not directly interchangeable.[5][4]

Co-use can increase overdose risk even when a person believes one substance will balance the other. Naloxone can reverse opioid effects but not the harmful effects of methamphetamine.[4]

Polystimulant use means using multiple stimulants. In 2021–2022 national survey data, people reporting polystimulant use had higher rates of psychological distress, suicidal thoughts, suicide attempts, and major depressive episodes than the other stimulant groups examined.[12] The study compared people during a defined period rather than following them over time. It cannot establish which factors caused those outcomes.[12]

A major depressive episode involves multiple depressive symptoms occurring together for at least two weeks, including depressed mood or loss of interest in activities. It is more than a brief period of feeling low.[13]

In the United States, call or text 988 or use the chat at 988lifeline.org for suicidal thoughts or urges to harm yourself.[3] Call 911 for a life-threatening emergency.[3]

Mental health symptoms deserve assessment even when someone uses methamphetamine. Integrated care means the professionals treating substance use and mental health work together. For example, your counselor and prescriber can coordinate a plan for both cravings and depression. Treating only one problem may leave the other interfering with recovery.[2]

Ask: “Who will coordinate my care, and how will my providers share updates with my permission?” Research does not establish that every combined-care program works equally well. The practical aim is to avoid leaving you to connect separate treatment plans on your own.[2]

Heart disease and opioid use can change treatment decisions. Other physical or mental health conditions also need individual assessment.[4][2]

Methamphetamine Treatment During Pregnancy

If you are pregnant and using methamphetamine, ask for both substance use treatment and prenatal care, the healthcare you receive during pregnancy. Ask for help now even if you have not arranged a pregnancy-care appointment. The services should work together. Your team can assess nutrition, infections, mental health, and practical needs such as transportation and social support.[2]

Treatment for Methamphetamine Use Disorder

Effective behavioral treatments are available for methamphetamine use disorder. Contingency management has the strongest evidence, and cognitive behavioral therapy and motivational interviewing are other evidence-based approaches. Assessment and a conversation about options can begin before someone feels fully ready to seek treatment.[1][2][7]

Withdrawal care addresses immediate symptoms and safety. Ongoing treatment helps you manage cravings, change patterns of use, and get care for other health conditions. Recovery also involves rebuilding daily life beyond the initial withdrawal period. Renewed use can be addressed in treatment: cognitive behavioral approaches include skills for returning to abstinence, meaning not using the substance, after recurrence.[2][5]

Psychiatrist Madhukar Trivedi, who led a medication study, told UT Southwestern in 2021 that “methamphetamine use disorder really disrupts people’s lives in many different ways.” The discussion included lost jobs and damaged relationships, alongside medical problems. Bring those everyday concerns into treatment conversations too.[14]

Contingency Management for Methamphetamine Use Disorder

Contingency management provides tangible incentives for treatment attendance or other agreed recovery-related behaviors, such as test results showing no stimulant use. Incentives may include prizes, vouchers, gift cards, or similar rewards.[1]

The Centers for Disease Control and Prevention describes contingency management as the most effective treatment for stimulant use disorder, while the National Institute on Drug Abuse calls it the best-studied behavioral treatment for methamphetamine use disorder and the approach most associated with treatment success.[4][1]

The practical idea is positive reinforcement: a tangible reward follows a recovery-related behavior, such as continuing treatment or not using methamphetamine. When considering a program, ask which behaviors earn incentives, how they are checked, what rewards are offered, and what attendance involves.[4][1]

Its limitations matter. The clinical review reports that participants need at least some intention to change their stimulant-use behavior. Contingency management is not available in every treatment setting, and financing and implementation barriers have limited access outside research and selected health systems.[5]

Cognitive Behavioral Therapy for Methamphetamine Use Disorder

Cognitive behavioral therapy, or CBT, helps you practice skills for situations in which you might use methamphetamine. A session may involve identifying what brings on a craving, practicing how to refuse an offer of drugs, or planning how to reconnect with treatment after using again. These skills are meant to be used between appointments.[5][2]

Some trials have found a “sleeper effect,” meaning abstinence outcomes improved over time as participants used the skills in real situations. Cognitive behavioral principles are also incorporated into peer support, harm reduction, and many treatment programs.[5]

Behavioral treatment takes mental effort, which stimulant use or withdrawal can make harder to sustain. If that is a barrier, ask the provider how sessions and between-session work could be made manageable. For example: “How would we adapt treatment if I am having trouble concentrating?”[5]

Motivational Counseling for Methamphetamine Treatment

Motivational interviewing is a counseling approach for discussing your own reasons for change, including uncertainty about treatment. You might talk about what methamphetamine does for you, what it is costing you, and what you would like to be different. Motivational enhancement therapy builds on these conversations. Neither is the same as medical withdrawal care.[2]

A counselor can help you choose a manageable goal and discuss a referral or next appointment. Research on motivational interviewing alone for stimulant use has mixed results, so it should not be presented as a guaranteed solution. Ask what other treatment and follow-up the program offers.[2]

Continuing Care and Peer Support for Methamphetamine Recovery

Group support, peer recovery services, and mutual-help groups may be part of support, but they are not identical to professional treatment. The 2024 National Survey on Drug Use and Health classified support groups and services from peer specialists or recovery coaches separately from substance use treatment.[13][1] The National Institute on Drug Abuse includes group support among evidence-based behavioral approaches.[13][1]

Stimulant use disorder can involve recurrence over time, and craving may continue for weeks or months after stopping. When considering care, ask what follow-up is offered, how to reconnect after renewed use, and how the program coordinates treatment of mental health symptoms.[5][2]

Medication Options for Methamphetamine Use Disorder

No medication is FDA-approved specifically for methamphetamine use disorder or other stimulant use disorders.[2][1]

Some placebo-controlled trials have found measurable reductions in stimulant use with selected medications or combinations, but results are not consistent enough to create a universal medication approach. Benefits may apply to defined outcomes and populations rather than everyone with methamphetamine use disorder.[5]

A clinician may consider off-label treatment, meaning an approved medicine used for a condition outside its FDA-approved labeling. One studied combination is injectable naltrexone and oral bupropion. Naltrexone is used for alcohol and opioid use disorders, and bupropion is used for depression and smoking cessation. Those uses do not mean the combination is suitable for everyone who uses methamphetamine.[15][14]

In the 12-week ADAPT-2 trial, the weighted average response rate across two study stages was 13.6% with the medicines and 2.5% with placebo.[15] A response meant at least three of four urine samples tested negative for methamphetamine near the end of a stage. This was a modest benefit for some adults, not evidence that most participants recovered or that the result would last indefinitely.[15]

Tell the prescriber about opioid use, including methadone or buprenorphine treatment. Naltrexone can trigger or worsen opioid withdrawal and cannot simply be added to those medicines. The ADAPT-2 findings do not establish a treatment plan for someone with both methamphetamine and opioid use disorders. A clinician needs to assess both conditions and the risks of changing treatment.[16][15]

Medication decisions require a clinician. Do not stop or change an existing treatment on your own to try this combination.

Reducing Risks From Methamphetamine Use

Reducing harm is worthwhile whether a person wants to stop, reduce use, or make no immediate change. It can occur alongside treatment and does not require denying the risks.

Useful steps include:

  • Avoid combining methamphetamine with opioids. Co-use can increase overdose risk even when the effects seem to balance each other.[4]
  • Keep naloxone available when opioid exposure is possible. Give it for slow or stopped breathing and seek emergency help, because stimulant complications may also need treatment.[1][4]
  • Consider available drug checking as a way to learn about the drug supply, not as a way to remove methamphetamine’s own risks.[1]
  • Use sterile injection equipment and do not share supplies, because sharing can transmit infections.[1]
  • Seek urgent medical help for signs of heart or blood-vessel complications, seizures, severe overheating, or dangerous psychosis, and seek assessment for concerning symptoms after injection.[4][2]
  • Maintain good oral hygiene and receive regular dental care.[8][1]

Choose a manageable starting point, such as keeping naloxone nearby or arranging dental care. If access is difficult, a practical question for a healthcare or harm-reduction service is: “Which of these needs can you help me address, and where else could I ask?”[1][2]

How Families and Friends Can Support Methamphetamine Recovery

Start with what you have noticed, not a diagnosis. For example: “I have noticed you are missing sleep, and I am worried. What kind of help would feel useful?”

Possible questions include: “Would you like help finding a program?” or “Would transportation or company at an appointment help?” Offer only what you can realistically provide, and let the person’s answer guide the next conversation.

Emergency department patients with methamphetamine use disorder interviewed in a 2022 Denver study described stigma, poor communication, inadequate referrals, and feeling that concerns were dismissed after substance use became known.[7] They favored empathetic, flexible care that recognized trauma and social needs and met people at their current level of readiness.[7]

That qualitative study included 18 adults in one urban healthcare system that serves people regardless of their ability to pay.[7] It offers detailed patient perspectives but does not show how common those experiences are in every emergency department.[7]

Family Training to Encourage Methamphetamine Treatment

Community Reinforcement and Family Training, known as CRAFT, is a family-focused approach intended to help concerned relatives or partners engage someone in substance use treatment while also addressing their own functioning and well-being. It offers a support option when the person using substances is reluctant to enter treatment.[17]

A systematic review (a structured synthesis of research) combined four randomized trials, which assigned participants to comparison groups by chance. Among 264 concerned relatives or partners, CRAFT produced about three times the treatment engagement of Al-Anon or Nar-Anon family-support approaches and about twice that of another structured treatment-entry approach, the Johnson Institute intervention.[17]

Approximately two-thirds of initially treatment-resistant people entered treatment, typically after four to six CRAFT sessions.[17] The outcome was entering treatment, not necessarily stopping substance use or sustaining recovery.[17]

The trials covered substance use disorders broadly rather than methamphetamine alone. CRAFT should therefore be understood as evidence for family-assisted engagement across substance problems, not proof of a methamphetamine-specific effect.[17]

Support for family members matters in its own right. In the review, concerned relatives or partners showed improvements in psychological, social, and physical well-being across all three approaches during the six-month treatment window. CRAFT’s advantage in treatment engagement should not be read as proof that the other approaches offer no benefit to families.[17]

Methamphetamine Use and Overdose Statistics in the United States

Population estimates answer different questions depending on the year, age range, setting, and definition used. “Past-year use,” for example, includes anyone who reports using during the previous 12 months. It does not show how often each person used, whether use was medically supervised, or whether the person had a disorder.

The Substance Abuse and Mental Health Services Administration’s 2025 National Survey on Drug Use and Health (NSDUH), published July 27, 2026, estimates that about 2.65 million people used methamphetamine during the past year.[18][19][20] About 1.81 million had past-year methamphetamine use disorder.[18][19][20] Both estimates describe U.S. civilians aged 12 or older living outside institutions such as prisons or long-term hospitals.[18][19][20]

What The 2025 Survey Estimated People Aged 12 Or Older Percentage Of That Population
Past-year methamphetamine use[18] 2,653,000[18] 0.9%[18]
Past-year methamphetamine use disorder[19] 1,807,000[19] 0.6%[19]

The counts and percentages come from NSDUH Tables 1.1A–B and 5.1A–B.[18][19][20] These are methamphetamine-specific population estimates, not broader stimulant totals. The percentages are shares of the full population covered by the survey, not just people who used methamphetamine. The survey does not directly represent people living in institutions.[18][19][20]

Citing the 2022 survey report, the National Institute on Drug Abuse states that nearly two out of three people aged 26 or older who reported past-year methamphetamine use met criteria for a substance use disorder.[1] This proportion describes disorder among people reporting use, not how common methamphetamine use is in the population, and not a prediction about every individual who uses it.[1]

A national analysis of 2021–2022 survey data included 117,103 respondents and found that stimulant use disorder was more prevalent and severe among people reporting methamphetamine-only, crack cocaine, or multiple-stimulant use than among those reporting only non-crack cocaine or nonmedical prescription stimulants.[12] Among people reporting methamphetamine-only use, 51.2% reported stimulant craving.[12]

That study was cross-sectional, meaning it measured characteristics during a defined period rather than following individuals over time. It can identify differences and associations, but it cannot establish that a particular stimulant caused every mental health symptom or personal outcome.[12]

U.S. Overdose Deaths Involving Methamphetamine and Other Stimulants

U.S. deaths involving psychostimulants with abuse potential increased from 2,266 in 2011 to 34,855 in 2023.[4] This death-certificate category consists mostly of methamphetamine but is not limited to it. It should therefore not be presented as an exact methamphetamine-only count.[4]

Provisional data (figures that are not yet final) indicated declines during 2024, but deaths remained well above 2011 levels.[4] Death certification and toxicology practices, meaning testing for drugs and other substances, vary. Some heart or blood-vessel deaths related to stimulant toxicity may not receive overdose-specific codes. These factors may lead to undercounting.[4]

Across overdose deaths during January 2021 through June 2024, nearly 60% involved a stimulant.[4] Seventy-three percent of stimulant-involved deaths also involved an opioid. These are proportions of overdose deaths, not proportions of people who use methamphetamine and not estimates of an individual’s chance of dying.[4]

Approximately 50,000 deaths during that three-and-a-half-year period involved stimulants without opioids, accounting for about 15% of all overdose deaths.[4] Stimulant-only emergencies therefore matter even though opioid co-involvement is prominent.[4]

Drug testing after death, investigative information, and death classification differ across jurisdictions. Some large states were excluded from parts of the circumstance analysis. The findings describe documented deaths and patterns. They cannot determine precisely which substance caused each death when multiple drugs or health conditions were involved.[4]

Finding Methamphetamine Treatment Near You or Online

When comparing local programs or online care, ask what the service actually provides for methamphetamine use. A counseling appointment, a program offering contingency management, and medical care for withdrawal or psychosis meet different needs. Online care may help you connect with treatment, but it cannot provide emergency medical care.[2]

Questions to ask before you book

  • Do you treat methamphetamine use disorder, and which treatments do you offer?
  • Can you provide contingency management, or refer me to a program that does?
  • Who handles medical concerns or urgent mental health symptoms?
  • Which appointments require an in-person visit?
  • Are you licensed to treat people where I live, and what will I pay?
  • How can I reconnect if I miss appointments or start using again?

If travel, cost, childcare, or privacy makes care difficult, say so when you call. Ask what assistance or alternatives are available. A listing does not confirm availability, insurance coverage, or that a particular program can meet your needs.

Next Steps for Methamphetamine Help and Recovery

If there are signs of a heart or blood-vessel emergency, a seizure, severe overheating, slowed or stopped breathing, or dangerous psychosis, seek emergency medical help now. Give naloxone if available when breathing is slow or stopped, because opioid involvement is possible. Naloxone does not replace treatment for stimulant complications.[4][1][2]

If there is no immediate emergency but use is causing concern, ask a healthcare professional or methamphetamine treatment program about an assessment. Useful questions include: “Do you assess stimulant use disorder?” “Do you provide contingency management?” “How do you address mental health conditions alongside substance use?” and “What follow-up can you offer?” These questions do not assume that every provider offers every service.[2][4]

If stopping feels out of reach, choose one risk-reduction step: keep naloxone available when opioid exposure is possible, avoid opioid-stimulant combinations, do not share injection equipment, or arrange dental care. Ask for help with whichever need feels most manageable now.[1][4][2]

If you are supporting someone else, consider asking about CRAFT or another family-support approach. The evidence supports family-assisted treatment engagement across substance use disorders, not a guaranteed result for any individual. You can also seek support for your own well-being.[17]

Renewed use does not make another treatment conversation pointless. Behavioral approaches include skills for returning to abstinence, and follow-up assessment can address continuing health concerns.[5][2] The next useful step can be an appointment to address the concern that feels most urgent to you.

If methamphetamine use is getting harder to manage, explore AddictionHelp’s Treatment Center Directory and ask about stimulant-use treatment, mental health assessment, and ongoing support.

You can also explore online therapy options for a conversation about the changes you want to make. Ask the provider about experience with methamphetamine recovery.

If you are thinking about suicide or harming yourself, call or text 988 in the United States. Call 911 for a life-threatening emergency.[3]

Frequently Asked Questions About Methamphetamine

Does Methamphetamine Use Always Mean Addiction?

No. Use, intoxication, physical dependence, and methamphetamine use disorder are different. A disorder requires at least two qualifying symptoms within 12 months plus serious distress or problems in daily life. Risk can still be serious before diagnostic criteria are met.[1]

Can Someone Have Withdrawal Without Methamphetamine Use Disorder?

Yes. A person who repeatedly uses methamphetamine may experience withdrawal after stopping even without meeting the full criteria for stimulant use disorder. Diagnosis depends on the broader pattern and consequences, not withdrawal alone.[1]

Can A Dental Examination Prove Methamphetamine Use?

No. Extensive decay and dry mouth may occur among people using methamphetamine, but these findings have multiple possible causes. In a 31-person inpatient pilot study, dental examinations did not distinguish methamphetamine users from people using other substances.[8][11]

Does Naloxone Reverse A Methamphetamine Overdose?

No. Naloxone reverses opioid effects, not the harmful effects of stimulants. It should still be given when breathing is slow or stopped because fentanyl, heroin, or another opioid may be involved. Seek emergency help because stimulant complications may need additional treatment.[4][1]

Is Methamphetamine-Related Psychosis Permanent?

Symptoms such as hearing voices or holding false beliefs can occur even when someone is not intoxicated and may recur after a previous methamphetamine-associated episode. That does not establish that symptoms will be permanent. A clinician must also consider another mental health condition and other substance use. Severe agitation or an immediate safety risk requires emergency assessment.[9][1][2]

Is There An Approved Medication For Methamphetamine Use Disorder?

No medication is FDA-approved specifically for methamphetamine use disorder. Behavioral treatments are available, with contingency management, which rewards agreed recovery goals, having the strongest evidence. Clinicians may consider certain medicines approved for other conditions after an individualized assessment, but no medication works reliably for everyone.[2][1]

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

20 Sources
  1. National Institute on Drug Abuse. (n.d.). Methamphetamine. Read source
  2. Substance Abuse and Mental Health Services Administration. (2021). Treatment for stimulant use disorders (Treatment Improvement Protocol Series 33). Read source
  3. National Institute of Mental Health. (n.d.). My mental health: Do I need help?. Read source
  4. Tanz, L. J., Miller, K. D., Dinwiddie, A. T., Gladden, R. M., Asher, A., Baldwin, G., Nesbit, B., & O’Donnell, J. (2025). Drug overdose deaths involving stimulants — United States, January 2018–June 2024. MMWR. Morbidity and Mortality Weekly Report, 74(32), 491–499. https://doi.org/10.15585/mmwr.mm7432a1 Read source
  5. Ciccarone, D., & Shoptaw, S. (2022). Understanding stimulant use and use disorders in a new era. Medical Clinics of North America, 106(1), 81–97. https://doi.org/10.1016/j.mcna.2021.08.010 Read source
  6. U.S. Food and Drug Administration. (2024, September). Desoxyn prescribing information. Read source
  7. Rinehart, D. J., Duarte, K. G., Gilbert, A., Al-Tayyib, A., Camfield, K., & Simpson, S. A. (2024). “If you plant that seed, it will grow”: A qualitative study to improve linkage to care among patients with methamphetamine use disorder in emergency department settings. Journal of Addiction Medicine, 18(6), 628–634. https://doi.org/10.1097/ADM.0000000000001315 Read source
  8. Hamamoto, D. T., & Rhodus, N. L. (2009). Methamphetamine abuse and dentistry. Oral Diseases, 15(1), 27–37. https://doi.org/10.1111/j.1601-0825.2008.01459.x Read source
  9. Caton, C. L., Samet, S., & Hasin, D. S. (2000). When acute-stage psychosis and substance use co-occur: Differentiating substance-induced and primary psychotic disorders. Journal of Psychiatric Practice, 6(5), 256–266. https://doi.org/10.1097/00131746-200009000-00006 Read source
  10. New York State Department of Health AIDS Institute. (2025, November 20). Clinical guidance: Stimulant use. Read source
  11. Cretzmeyer, M., Walker, J., Hall, J. A., & Arndt, S. (2007). Methamphetamine use and dental disease: Results of a pilot study. Journal of Dentistry for Children, 74(2), 85–92. Read source
  12. Truchan, J., Schepis, T. S., Pasman, E., McCabe, V. V., & McCabe, S. E. (2026). DSM-5 stimulant use disorder severity, stimulant craving, and other clinical characteristics based on stimulant type (cocaine, methamphetamine, nonmedical prescription stimulants, or polystimulants). Journal of Addiction Medicine, 20(4), 428–436. https://doi.org/10.1097/ADM.0000000000001563 Read source
  13. Substance Abuse and Mental Health Services Administration. (2025). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health. Read source
  14. UT Southwestern Medical Center. (2021, January 13). New combination drug therapy offers hope against methamphetamine addiction. Read source
  15. Trivedi, M. H., Walker, R., Ling, W., Dela Cruz, A., Sharma, G., Carmody, T., Ghitza, U. E., Wahle, A., Kim, M., Shores-Wilson, K., Sparenborg, S., Coffin, P., Schmitz, J., Wiest, K., Bart, G., Sonne, S. C., Wakhlu, S., Rush, A. J., Nunes, E. V., & Shoptaw, S. (2021). Bupropion and naltrexone in methamphetamine use disorder. The New England Journal of Medicine, 384(2), 140–153. https://doi.org/10.1056/NEJMoa2020214 Read source
  16. American Society of Health-System Pharmacists. (2026, September 15). Naltrexone injection. MedlinePlus. Read source
  17. Roozen, H. G., de Waart, R., & van der Kroft, P. (2010). Community reinforcement and family training: An effective option to engage treatment-resistant substance-abusing individuals in treatment. Addiction, 105(10), 1729–1738. https://doi.org/10.1111/j.1360-0443.2010.03016.x Read source
  18. Substance Abuse and Mental Health Services Administration. (2026a). 2025 NSDUH detailed tables: Tables 1.1A–B. Read source
  19. Substance Abuse and Mental Health Services Administration. (2026b). 2025 NSDUH detailed tables: Tables 5.1A–B. Read source
  20. Substance Abuse and Mental Health Services Administration. (2026, July 27). 2025 NSDUH detailed tables. Read source
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.